
Tuesday, July 30
FT News Briefing
00:00
Shifting Strategies in the Pharmaceutical Industry
This chapter explores the financial aspects of the pharmaceutical industry, highlighting Pfizer's shift in business strategy through the spin-off of its Upjohn unit and its merger with Mylan. It focuses on Pfizer's intent to concentrate on innovative medications while moving away from non-generic products.
Play episode from 05:36
Transcript


